Brian Freed
![Brian Freed Brian Freed](https://as-immunetolerance.com/wp-content/uploads/sites/160/2023/11/Brian-Freed-Speaker-Headshot-150x150.png)
Company: RheumaGen
Job title: Co-Founder & Chief Scientific Officer
Seminars:
Introducing Genetic Tolerance Through HLA Gene Editing: Evaluating the Preclinical Data & Regulatory Feedback 2:45 pm
Identifying antigen-specific HLA gene-editing targets with bioinformatics and novel assays Editing the HLA gene without immunosuppression or rejection Reviewing the preclinical data and FDA feedback for Rheumagen’s lead indication of treatment-resistant rheumatoid arthritisRead more
day: Conference Day Two